-
高血压是心脑血管疾病的重要危险因素。原发性高血压同时合并有高同型半胱氨酸(homocysteine,Hcy)血症称为H型高血压[1]。在2010版《中国高血压防治指南》将Hcy≥10 μmol/L称为高Hcy血症[2]。在《中国高血压防治指南(2018年修订版)》中将高Hcy血症标准调整为≥15 μmol/L[3]。高血压合并高Hcy血症能明显增加心脑血管事件的发生率,特别是脑卒中的发病率[4-6]。亚甲基四氢叶酸还原酶(MTHFR)作为Hcy代谢的重要关键酶,其基因的多态性,特别是C677T位点的基因突变可导致酶的活性发生改变;叶酸作为Hcy代谢的重要原料,其缺乏可导致Hcy代谢出现障碍[7-8]。本研究通过检测高血压病人血浆Hcy水平及MTHFR 677C/T基因类型,分析高血压病人血浆Hcy与MTHFR 677C/T基因多态性的相关性,并评价在不同基因类型间给予不同剂量叶酸的干预效果。
-
共筛查359名高血压病人,合并有高Hcy血症119例,发病率为55.43%。男性病人高Hcy血症发生率及血浆Hcy水平均明显高于女性(P < 0.01)(见表 1)。MTHFR 677C/T基因检测结果显示,359例病人中CC型161, CT型118例, TT型80例,TT型高血压病人发生高Hcy血症的比例及血浆Hcy均高于CC型和CT型(P < 0.01)(见表 1)。
变量 n 高Hcy血症 Hcy/(μmol/L) 性别 男 179 116(64.80) 18.58±7.29 女 180 83(46.11) 15.48±6.61 t — 12.70* 4.22 P — < 0.01 < 0.01 基因 CC型 161 64(39.75) 15.22±6.11 CT型 118 75(63.56) 17.76±6.77 TT型 80 80(80.00) 20.79±7.97 t — 82.03* 18.46 P — < 0.01 < 0.01 *示χ2值 表 1 不同性别与基因类型高血压病人合并高Hcy血症比例及血浆Hcy水平比较(x±s)
-
干预前后同种基因型在0.8 mg组和5 mg组血浆Hcy水平差异无统计学意义(P > 0.05)。0.8 mg组和5 mg组不同基因类型干预后的血浆Hcy水平较干预前均明显下降(P < 0.01);干预后组内不同基因型Hcy水平差异有统计学意义(P < 0.01),0.8 mg组和5 mg组中CC型Hcy水平低于CT和TT型(P < 0.05);0.8 mg组CT型Hcy水平低于TT型(P < 0.05)(见表 2)。
分组 n CC型 CT型 TT型 F P MS组内 干预前 0.8 mg组 25 21.62±6.69 22.92±4.17 24.02±4.39 1.35 > 0.05 27.139 5 mg组 25 21.25±5.31 24.27±7.93 25.99±7.08 3.06 > 0.05 47.069 t — 0.22 0.75 1.18 — — — P — > 0.05 > 0.05 > 0.05 — — — 干预后 0.8 mg组 25 10.14±3.33** 13.04±2.52**▲ 15.14±3.11**▲■ 17.44 < 0.01 9.037 5 mg组 25 10.28±2.87** 15.27±5.40**▲ 17.14±5.38**▲ 14.22 < 0.01 22.114 t — 0.16 1.87 1.61 — — — P — > 0.05 > 0.05 > 0.05 — — — 组内比较**P < 0.01;q检验:与CC型比较▲P < 0.05;与CT型比较■P < 0.05 表 2 各基因类型干预前后血浆Hcy水平比较(x±s;μmol/L)
高血压病人同型半胱氨酸与MTHFR 677C/T基因多态性相关性研究及不同剂量叶酸干预效果评价
Study on the relationship between homocysteine and MTHFR 677C/T gene polymorphism in patients with hypertension and evaluation on the effect of different doses of folic acid intervention
-
摘要:
目的探讨高血压病人同型半胱氨酸(Hcy)水平与MTHFR 677C/T基因多态性的相关性,评价不同剂量叶酸治疗不同基因型高Hcy血症效果。 方法筛选高血压病人359例,进行Hcy筛查及MTHFR 677C/T基因检测,根据基因类型分为CC型、CT型和TT型,每种基因类型筛选50例病人,随机分为2组,各25例,给予0.8 mg和5 mg叶酸治疗8周,评价治疗效果。 结果359例高血压病人中合并有高Hcy血症119例,发病率为55.43%。男性病人高Hcy血症发生率及血浆Hcy水平均明显高于女性(P < 0.01)。MTHFR 677C/T基因检测结果显示,359例病人中CC型161例,CT型118例,TT型80例,TT型高血压病人发生高Hcy血症的比例及血浆Hcy均高于CC型和CT型(P < 0.01)。干预前后同种基因型在0.8 mg组和5 mg组血浆Hcy水平差异无统计学意义(P > 0.05)。0.8 mg组和5 mg组不同基因类型干预后的血浆Hcy水平较干预前均明显下降(P < 0.01);干预后组内不同基因型Hcy水平差异有统计学意义(P < 0.01),0.8 mg组和5 mg组中CC型Hcy水平低于CT和TT型(P < 0.05);0.8 mg组CT型Hcy水平低于TT型(P < 0.05)。 结论Hcy水平与MTHFR 677C/T基因多态性存在相关性,叶酸能有效降低Hcy水平,大剂量叶酸与较小剂量叶酸干预效果无明显差异。基因类型不同,叶酸干预效果存在差异。 -
关键词:
- 高血压 /
- 同型半胱氨酸 /
- MTHFR 677C/T基因多态性 /
- 叶酸
Abstract:ObjectiveTo investigate the correlation between homocysteine(Hcy) level and MTHFR 677C/T gene polymorphism in patients with hypertension, and evaluate the effect of different doses of folic acid on different genotypes of hyperhomocysteinemia. MethodsThree hundred and fifty-nine patients with hypertension were screened for Hcy screening and MTHFR 677C/T gene detection. The gene type was divided into type CC, CT and TT, and 50 patients in each gene type were randomly divided into two groups(25 cases in each group), who were treated with 0.8 mg and 5 mg folic acid for 8 weeks to evaluate the therapeutic effect. ResultsAmong 359 hypertensive patients, 119 cases were combined with hyperhomocysteinemia, and the incidence rate was 55.43%. The incidence of hyperhomocysteinemia and plasma Hcy level in male patients were significantly higher than those in female patients(P < 0.01). The results of MTHFR 677C/T gene detection showed that among 359 patients, 161 cases were with type CC, 118 cases were with type CT, and 80 cases were with type TT. The incidence of hyperhomocysteinemia and plasma Hcy level in type TT hypertensive patients were higher than those in type CC and type CT patients(P < 0.01). There was no significant difference in plasma Hcy level between 0.8 mg group and 5 mg group of the same gene type before and after intervention(P > 0.05). The plasma Hcy level in 0.8 mg group and 5 mg group of different gene type was significantly lower than those before intervention(P < 0.01). The difference of Hcy level in different gene type in the same group after intervention was statistically significant(P < 0.01), the Hcy level of type CC in 0.8 mg group and 5 mg group was lower than that of type CT and TT(P < 0.05), and Hcy level of type CT in 0.8 mg group was lower than that of type TT(P < 0.05). ConclusionsThe Hcy level is correlated with MTHFR 677C/T gene polymorphism.Folic acid can effectively reduce hyperhomocysteinemia. There is no significant difference between high-dose folic acid and low-dose folic acid. The effect of folic acid intervention was different with different gene types. -
Key words:
- hypertension /
- homocysteine /
- MTHFR 677C/T gene polymorphism /
- folic acid
-
表 1 不同性别与基因类型高血压病人合并高Hcy血症比例及血浆Hcy水平比较(x±s)
变量 n 高Hcy血症 Hcy/(μmol/L) 性别 男 179 116(64.80) 18.58±7.29 女 180 83(46.11) 15.48±6.61 t — 12.70* 4.22 P — < 0.01 < 0.01 基因 CC型 161 64(39.75) 15.22±6.11 CT型 118 75(63.56) 17.76±6.77 TT型 80 80(80.00) 20.79±7.97 t — 82.03* 18.46 P — < 0.01 < 0.01 *示χ2值 表 2 各基因类型干预前后血浆Hcy水平比较(x±s;μmol/L)
分组 n CC型 CT型 TT型 F P MS组内 干预前 0.8 mg组 25 21.62±6.69 22.92±4.17 24.02±4.39 1.35 > 0.05 27.139 5 mg组 25 21.25±5.31 24.27±7.93 25.99±7.08 3.06 > 0.05 47.069 t — 0.22 0.75 1.18 — — — P — > 0.05 > 0.05 > 0.05 — — — 干预后 0.8 mg组 25 10.14±3.33** 13.04±2.52**▲ 15.14±3.11**▲■ 17.44 < 0.01 9.037 5 mg组 25 10.28±2.87** 15.27±5.40**▲ 17.14±5.38**▲ 14.22 < 0.01 22.114 t — 0.16 1.87 1.61 — — — P — > 0.05 > 0.05 > 0.05 — — — 组内比较**P < 0.01;q检验:与CC型比较▲P < 0.05;与CT型比较■P < 0.05 -
[1] 李建平, 卢新政, 霍勇, 等. H型高血压诊断与治疗专家共识[J]. 中华高血压杂志, 2016, 24(2): 123. [2] 中国高血压防治指南修订委员会. 中国高血压防治指南2010[J]. 中华心血管病杂志, 2011, 39(7): 579. doi: 10.3760/cma.j.issn.0253-3758.2011.07.002 [3] 中国高血压防治指南修订委员会. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1): 24. doi: 10.3969/j.issn.1007-5410.2019.01.002 [4] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2014[J]. 中华神经科杂志, 2015, 48(4): 246. doi: 10.3760/cma.j.issn.1006-7876.2015.04.002 [5] AZAD MAK, HUANG P, LIU G, et al. Hyperhomocysteinemia and cardiovascular disease in animal model[J]. Amino Acids, 2018, 50(1): 3. doi: 10.1007/s00726-017-2503-5 [6] LI SH, ZHU JM, WU L, et al. The association between plasma homocysteine and ambulatory blood pressure variability in patients with untreated hypertension[J]. Clin Chim Acta, 2018, 477(2): 32. [7] MOLL S, VARGA EA. Homocysteine and MTHFR mutations[J]. Circulation, 2015, 132(1): 6. [8] YUN L, XU R, LI GH, et al. Homocysteine and the C677T gene polymorphism of its key metabolic enzyme MTHFR are risk factors of early renal damage in hypertension in a chinese han population[J]. Medicine(Baltimore), 2015, 94(52): e2389. [9] JJ UZELAC, STANIC M, KRSTIC D, et al. Effects of homocysteine and its related compounds on oxygen consumption of the rat heart tissue homogenate: the role of different gasotransmitters[J]. Mol Cell Biochem, 2018, 444(1): 143. [10] 裴东旭, 李永伟, 刘心伟. 老年脑卒中患者Hcy、Lp-PLA2和CysC联合检测的意义[J]. 中国老年学杂志, 2019, 39(2): 273. doi: 10.3969/j.issn.1005-9202.2019.02.006 [11] TAN B, VENKETASUBRAMANIAN N, VROOMAN H, et al. Homocysteine and cerebral atrophy: The epidemiology of dementia in Singapore study[J]. J Alzheimers Dis, 2018, 62(2): 877. doi: 10.3233/JAD-170796 [12] TIAN S, HAN J, HUANG R, et al. Increased plasma homocysteine level is associated with executive dysfunction in type 2 diabetic patients with mild cognitive impairment[J]. J Alzheimers Dis, 2017, 58(4): 1163. doi: 10.3233/JAD-170162 [13] 陈黎明, 王小泉, 王祖森. 晚发性抑郁症病人同型半胱氨酸水平和认知功能的研究[J]. 蚌埠医学院学报, 2020, 45(6): 815. [14] KUMAR M, GOUDIHALLI S, MUKHERJEE K, et al. Methylenetetrahydrofolate reductase C677T variant and hyperhomocysteinemia in subarachnoid hemorrhage patients from India[J]. Metab Brain Dis, 2018, 33(5): 1617. doi: 10.1007/s11011-018-0268-5 [15] LI AF, SHI YS, XU LY, et al. A possible synergistic effect of MTHFR C677T polymorphism on homocysteine level variations increased risk for ischemic stroke[J]. Medicine(Baltimore), 2017, 96(51): e9300. [16] 周丽萍, 乔義, 刘毓刚, 等. 血清同型半胱氨酸及其代谢相关基因MTHFR多态性与缺血性脑卒中发生及预后的关系[J]. 标记免疫分析及临床, 2017, 24(3): 241. [17] CAI WJ, YIN L, YANG F, et al. Association between Hcy levels and the CBS844ins68 and MTHFR C677T polymorphisms with essential hypertension[J]. Biomed Rep, 2014, 2(6): 861. doi: 10.3892/br.2014.357 [18] ZENG Q, LI F, XIANG TY, et al. Influence of food groups on plasma total homocysteine for specific MTHFR C677T genotypes in Chinese population[J]. Mol Nutr Food Res, 2017, 61(2): 1600351. doi: 10.1002/mnfr.201600351 [19] 仇冬霞. 不同基因型H型高血压病人血压和血浆同型半胱氨酸水平比较及补充叶酸对其的影响[J]. 蚌埠医学院学报, 2019, 44(12): 1601. [20] 唐妍妍, 段顺延, 吴辉丽, 等. 不同剂量叶酸片对脑梗塞患者血同型半胱氨酸的影响[J]. 现代医药卫生, 2019, 35(2): 248. doi: 10.3969/j.issn.1009-5519.2019.02.026 [21] 文海英, 赖小文, 黄楷森. 依那普利联合叶酸治疗老年H型高血压病对患者炎性因子和血管内皮功能的影响[J]. 临床误诊误治, 2019, 32(2): 22. doi: 10.3969/j.issn.1002-3429.2019.02.006